These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
357 related articles for article (PubMed ID: 29032160)
1. Multimodal treatment including hysterectomy improves survival in patients with locally advanced cervical cancer: A population-based, propensity score-matched analysis. Wu SG; Zhang WW; Sun JY; Li FY; He ZY; Zhou J Int J Surg; 2017 Dec; 48():122-127. PubMed ID: 29032160 [TBL] [Abstract][Full Text] [Related]
2. Outcome of international Federation of gynecology and obstetrics stage IIb cervical cancer from 2003 to 2012: an evaluation of treatments and prognosis: a retrospective study. Guo L; Liu X; Wang L; Sun H; Huang K; Li X; Tang F; Li S; Yuan X; Wang C Int J Gynecol Cancer; 2015 Jun; 25(5):910-8. PubMed ID: 25867278 [TBL] [Abstract][Full Text] [Related]
3. The prognostic value of histologic subtype in node-positive early-stage cervical cancer after hysterectomy and adjuvant radiotherapy. Zhou J; Zhang WW; Wu SG; He ZY; Sun JY; Yang GF; Li FY Int J Surg; 2017 Aug; 44():1-6. PubMed ID: 28583891 [TBL] [Abstract][Full Text] [Related]
4. Survival benefits with the addition of adjuvant hysterectomy to radiochemotherapy for treatment of stage I-II adenocarcinoma of the uterine cervix. Huang XB; Zhang WW; Wu SG; Sun JY; He ZY; Zhou J J Surg Oncol; 2018 Sep; 118(3):574-580. PubMed ID: 30114328 [TBL] [Abstract][Full Text] [Related]
5. Early-stage node negative cervical adenocarcinoma and squamous cell carcinoma show similar survival outcomes after hysterectomy: a population-based study. Wu SG; Sun JY; He ZY; Chen QH; Zhou J J Gynecol Oncol; 2017 Nov; 28(6):e81. PubMed ID: 29027399 [TBL] [Abstract][Full Text] [Related]
6. [Analysis of prognostic factors and therapeutic patterns of recurrent stage Ⅰb-Ⅱa cervical squamous carcinoma treated with radical hysterectomy]. Ou ZJ; Zhao D; An JS; Sun CY; Huang MN; Li B; Wu LY Zhonghua Fu Chan Ke Za Zhi; 2019 Jun; 54(6):399-405. PubMed ID: 31262124 [No Abstract] [Full Text] [Related]
7. [Prognostic analysis of stage Ⅰb2 andⅡa2 cervical squamous cancer without high risk factors treated with neo-adjuvant chemotherapy and radical hysterectomy]. Li PP; Li B; Wang YT; Liu SH; Zhang YN; Zhang R; Bai P; Li XG; Wu LY Zhonghua Fu Chan Ke Za Zhi; 2018 Apr; 53(4):248-256. PubMed ID: 29747270 [No Abstract] [Full Text] [Related]
8. Adenocarcinoma histology is a poor prognostic factor in locally advanced cervical cancer. Jonska-Gmyrek J; Gmyrek L; Zolciak-Siwinska A; Kowalska M; Kotowicz B Curr Med Res Opin; 2019 Apr; 35(4):595-601. PubMed ID: 30019594 [TBL] [Abstract][Full Text] [Related]
9. Definite chemoradiotherapy is a competent treatment option in FIGO stage IB2 cervical cancer compared with radical surgery +/- neoadjuvant chemotherapy. Hsieh HY; Huang JW; Lu CH; Lin JC; Wang L J Formos Med Assoc; 2019 Jan; 118(1 Pt 1):99-108. PubMed ID: 29429800 [TBL] [Abstract][Full Text] [Related]
10. Clinical behaviors and outcomes for adenocarcinoma or adenosquamous carcinoma of cervix treated by radical hysterectomy and adjuvant radiotherapy or chemoradiotherapy. Huang YT; Wang CC; Tsai CS; Lai CH; Chang TC; Chou HH; Lee SP; Hong JH Int J Radiat Oncol Biol Phys; 2012 Oct; 84(2):420-7. PubMed ID: 22365621 [TBL] [Abstract][Full Text] [Related]
11. Comparison of salvage therapies for isolated para-aortic lymph node recurrence in patients with uterine cervical cancer after definitive treatment. Kubota H; Tsujino K; Sulaiman NS; Sekii S; Matsumoto Y; Ota Y; Soejima T; Yamaguchi S; Sasaki R Radiat Oncol; 2019 Dec; 14(1):236. PubMed ID: 31878944 [TBL] [Abstract][Full Text] [Related]
12. Propensity Score Analysis of Radical Hysterectomy Versus Definitive Chemoradiation for FIGO Stage IIB Cervical Cancer. Tomita N; Mizuno M; Makita C; Kondo S; Mori M; Sakata J; Tsubouchi H; Hirata K; Tachibana H; Kodaira T Int J Gynecol Cancer; 2018 Oct; 28(8):1576-1583. PubMed ID: 30095702 [TBL] [Abstract][Full Text] [Related]
13. [Outcomes and prognostic factors of distant metastasis in patients with advanced cervical squamous cell carcinoma treated with concurrent chemoradiotherapy]. Ma R; Zhang H; Zou L; Qu Y Zhonghua Fu Chan Ke Za Zhi; 2015 Feb; 50(2):125-30. PubMed ID: 25877610 [TBL] [Abstract][Full Text] [Related]
14. Impact of the addition of concurrent chemotherapy to pelvic radiotherapy in surgically treated stage IB1-IIB cervical cancer patients with intermediate-risk or high-risk factors: a 13-year experience. Okazawa M; Mabuchi S; Isohashi F; Suzuki O; Yoshioka Y; Sasano T; Ohta Y; Kamiura S; Ogawa K; Kimura T Int J Gynecol Cancer; 2013 Mar; 23(3):567-75. PubMed ID: 23385284 [TBL] [Abstract][Full Text] [Related]
15. Can chemotherapy boost the survival benefit of adjuvant radiotherapy in early stage cervical cancer with intermediate risk factors? A population based study. Mahmoud O; Hathout L; Shaaban SG; Elshaikh MA; Beriwal S; Small W Gynecol Oncol; 2016 Dec; 143(3):539-544. PubMed ID: 27769525 [TBL] [Abstract][Full Text] [Related]
16. Populational trends and outcomes of postoperative radiotherapy for high-risk early-stage cervical cancer with lymph node metastasis: concurrent chemo-radiotherapy versus radiotherapy alone. Matsuo K; Nusbaum DJ; Machida H; Huang Y; Khetan V; Matsuzaki S; Klar M; Grubbs BH; Roman LD; Wright JD Am J Obstet Gynecol; 2020 May; 222(5):484.e1-484.e15. PubMed ID: 31678092 [TBL] [Abstract][Full Text] [Related]
17. Evaluation of the efficacy of prophylactic extended field irradiation in the concomitant chemoradiotherapy treatment of locally advanced cervical cancer, stage IIIB in the 2018 FIGO classification. Meng Q; Liu X; Wang W; Hou X; Lian X; Sun S; Yan J; Liu Z; Miao Z; Hu K; Zhang F Radiat Oncol; 2019 Dec; 14(1):228. PubMed ID: 31842919 [TBL] [Abstract][Full Text] [Related]
18. [Outcomes and prognostic factors of advanced squamous cervical cancer after concurrent chemoradiotherapy]. Binbin T; Lingying W; Manni H; Jusheng A; Ning L Zhonghua Fu Chan Ke Za Zhi; 2014 May; 49(5):348-54. PubMed ID: 25030731 [TBL] [Abstract][Full Text] [Related]
19. [Establishment of a prognostic nomogram and discussion on optimal treatment for cervical adenocarcinoma:a retrospective study based on SEER database and Chinese single-center data]. Li X; Gao YH; Yang Z; Ma Y; Liu C; Liu GC; Wang DB Zhonghua Fu Chan Ke Za Zhi; 2024 Apr; 59(4):307-319. PubMed ID: 38644277 [No Abstract] [Full Text] [Related]
20. Can surgery boost the survival benefit of chemoradiotherapy in T1b1-T2a1 stage cervical cancer with lymph node metastasis? A population-based study. Wang Y; Lyu Y; Che X; Li J; Feng W J Gynecol Oncol; 2024 May; 35(3):e36. PubMed ID: 38216135 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]